Literature DB >> 23813441

Seven-tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory process.

Martina Absinta1, Pascal Sati, María I Gaitán, Pietro Maggi, Irene C M Cortese, Massimo Filippi, Daniel S Reich.   

Abstract

OBJECTIVE: In multiple sclerosis (MS), accurate, in vivo characterization of dynamic inflammatory pathological changes occurring in newly forming lesions could have major implications for understanding disease pathogenesis and mechanisms of tissue destruction. Here, we investigated the potential of ultrahigh-field magnetic resonance imaging (MRI; 7T), particularly phase imaging combined with dynamic contrast enhancement, to provide new insights in acute MS lesions.
METHODS: Sixteen active MS patients were studied at 7T. Noncontrast, high-resolution T2* magnitude and phase scans, T1 scans before/after gadolinium contrast injection, and dynamic contrast-enhanced (DCE) T1 scans were acquired. T2*/phase features and DCE pattern were determined for acute and chronic lesions. When possible, 1-year follow-up 7T MRI was performed.
RESULTS: Of 49 contrast-enhancing lesions, 44 could be analyzed. Centrifugal DCE lesions appeared isointense or hypointense on phase images, whereas centripetal DCE lesions showed thin, hypointense phase rims that clearly colocalized with the initial site of contrast enhancement. This pattern generally disappeared once enhancement resolved. Conversely, in 43 chronic lesions also selected for the presence of hypointense phase rims, the findings were stable over time, and the rims were typically thicker and darker. These considerations suggest different underlying pathological processes in the 2 lesion types.
INTERPRETATION: Ultrahigh-field MRI and, especially, phase contrast, are highly sensitive to tissue changes in acute MS lesions, which differ from the patterns seen in chronic lesions. In acute lesions, the hypointense phase rim reflects the expanding inflammatory edge and may directly correspond to inflammatory byproducts and sequelae of blood-brain barrier opening.
© 2013 American Neurological Association.

Entities:  

Mesh:

Year:  2013        PMID: 23813441      PMCID: PMC3812397          DOI: 10.1002/ana.23959

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  33 in total

1.  A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis.

Authors:  Wei Bian; Kristin Harter; Kathryn E Hammond-Rosenbluth; Janine M Lupo; Duan Xu; Douglas Ac Kelley; Daniel B Vigneron; Sarah J Nelson; Daniel Pelletier
Journal:  Mult Scler       Date:  2012-05-28       Impact factor: 6.312

2.  Differentiation of pyogenic brain abscesses from necrotic glioblastomas with use of susceptibility-weighted imaging.

Authors:  C H Toh; K-C Wei; C-N Chang; P-W Hsu; H-F Wong; S-H Ng; M Castillo; C-P Lin
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-15       Impact factor: 3.825

Review 3.  Oligodendrocytes and the early multiple sclerosis lesion.

Authors:  John W Prineas; John D E Parratt
Journal:  Ann Neurol       Date:  2012-07       Impact factor: 10.422

4.  Detection of active plaques in multiple sclerosis using susceptibility-weighted imaging: comparison with gadolinium-enhanced MR imaging.

Authors:  Masako Suzuki; Kohsuke Kudo; Makoto Sasaki; Satoshi Takahashi; Jyunko Takahashi; Noriyuki Fujima; Ikuko Uwano; Hisashi Yonezawa; Masako Kudo; Hikoaki Fukaura; Naoki Ishizuka; Yasuo Terayama
Journal:  Magn Reson Med Sci       Date:  2011       Impact factor: 2.471

5.  Inflammatory cortical demyelination in early multiple sclerosis.

Authors:  Claudia F Lucchinetti; Bogdan F G Popescu; Reem F Bunyan; Natalia M Moll; Shanu F Roemer; Hans Lassmann; Wolfgang Brück; Joseph E Parisi; Bernd W Scheithauer; Caterina Giannini; Stephen D Weigand; Jay Mandrekar; Richard M Ransohoff
Journal:  N Engl J Med       Date:  2011-12-08       Impact factor: 91.245

6.  Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis.

Authors:  Dmitriy A Yablonskiy; Jie Luo; Alexander L Sukstanskii; Aditi Iyer; Anne H Cross
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

7.  In vivo quantification of T₂ anisotropy in white matter fibers in marmoset monkeys.

Authors:  Pascal Sati; Afonso C Silva; Peter van Gelderen; Maria I Gaitan; Jillian E Wohler; Steven Jacobson; Jeff H Duyn; Daniel S Reich
Journal:  Neuroimage       Date:  2011-08-27       Impact factor: 6.556

8.  Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla.

Authors:  Francesca Bagnato; Simon Hametner; Bing Yao; Peter van Gelderen; Hellmut Merkle; Fredric K Cantor; Hans Lassmann; Jeff H Duyn
Journal:  Brain       Date:  2011-12       Impact factor: 13.501

9.  Initial investigation of the blood-brain barrier in MS lesions at 7 tesla.

Authors:  María I Gaitán; Pascal Sati; Souheil J Inati; Daniel S Reich
Journal:  Mult Scler       Date:  2012-12-17       Impact factor: 6.312

10.  Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions.

Authors:  Veela Mehta; Wei Pei; Grant Yang; Suyang Li; Eashwar Swamy; Aaron Boster; Petra Schmalbrock; David Pitt
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

View more
  57 in total

Review 1.  The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Authors:  Kedar R Mahajan; Daniel Ontaneda
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 2.  Nonconventional MRI and microstructural cerebral changes in multiple sclerosis.

Authors:  Christian Enzinger; Frederik Barkhof; Olga Ciccarelli; Massimo Filippi; Ludwig Kappos; Maria A Rocca; Stefan Ropele; Àlex Rovira; Torben Schneider; Nicola de Stefano; Hugo Vrenken; Claudia Wheeler-Kingshott; Jens Wuerfel; Franz Fazekas
Journal:  Nat Rev Neurol       Date:  2015-11-03       Impact factor: 42.937

3.  Scan-stratified case-control sampling for modeling blood-brain barrier integrity in multiple sclerosis.

Authors:  Gina-Maria Pomann; Elizabeth M Sweeney; Daniel S Reich; Ana-Maria Staicu; Russell T Shinohara
Journal:  Stat Med       Date:  2015-05-04       Impact factor: 2.373

4.  Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions.

Authors:  Martina Absinta; Pascal Sati; Matthew Schindler; Emily C Leibovitch; Joan Ohayon; Tianxia Wu; Alessandro Meani; Massimo Filippi; Steven Jacobson; Irene C M Cortese; Daniel S Reich
Journal:  J Clin Invest       Date:  2016-06-06       Impact factor: 14.808

5.  Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.

Authors:  Ulrike W Kaunzner; Yeona Kang; Shun Zhang; Eric Morris; Yihao Yao; Sneha Pandya; Sandra M Hurtado Rua; Calvin Park; Kelly M Gillen; Thanh D Nguyen; Yi Wang; David Pitt; Susan A Gauthier
Journal:  Brain       Date:  2019-01-01       Impact factor: 13.501

Review 6.  Nanomaterial applications in multiple sclerosis inflamed brain.

Authors:  Clara Ballerini; Giovanni Baldi; Alessandra Aldinucci; Pietro Maggi
Journal:  J Neuroimmune Pharmacol       Date:  2015-01-24       Impact factor: 4.147

Review 7.  Perspectives of Ultra-High-Field MRI in Neuroradiology.

Authors:  E R Gizewski; C Mönninghoff; M Forsting
Journal:  Clin Neuroradiol       Date:  2015-07-17       Impact factor: 3.649

Review 8.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.

Authors:  Àlex Rovira; Mike P Wattjes; Mar Tintoré; Carmen Tur; Tarek A Yousry; Maria P Sormani; Nicola De Stefano; Massimo Filippi; Cristina Auger; Maria A Rocca; Frederik Barkhof; Franz Fazekas; Ludwig Kappos; Chris Polman; David Miller; Xavier Montalban
Journal:  Nat Rev Neurol       Date:  2015-07-07       Impact factor: 42.937

Review 9.  MRI in the assessment and monitoring of multiple sclerosis: an update on best practice.

Authors:  Ulrike W Kaunzner; Susan A Gauthier
Journal:  Ther Adv Neurol Disord       Date:  2017-05-12       Impact factor: 6.570

10.  Identification of Chronic Active Multiple Sclerosis Lesions on 3T MRI.

Authors:  M Absinta; P Sati; A Fechner; M K Schindler; G Nair; D S Reich
Journal:  AJNR Am J Neuroradiol       Date:  2018-05-03       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.